(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-0.15%) $77.99
(0.37%) $2.15
(0.06%) $2 310.10
(0.36%) $26.79
(0.09%) $966.20
(-0.31%) $0.929
(-1.07%) $10.87
(-0.13%) $0.797
(0.35%) $91.45
-3.39% $ 75.53
@ $77.33
Emitido: 3 may 2024 @ 09:57
Retorno: -2.32%
Señal anterior: may 2 - 09:30
Señal anterior:
Retorno: 1.82 %
Live Chart Being Loaded With Signals
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide...
Stats | |
---|---|
Volumen de hoy | 1.84M |
Volumen promedio | 907 554 |
Capitalización de mercado | 5.24B |
EPS | $0 ( 2024-05-02 ) |
Próxima fecha de ganancias | ( $1.660 ) 2024-08-01 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 11.51 |
ATR14 | $5.02 (6.65%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-17 | Niedzwiecki Daniel | Sell | 177 | Common Stock |
2024-04-17 | Blanchfield Paul | Sell | 455 | Common Stock |
2024-04-15 | Sabens Andrea | Sell | 341 | Common Stock |
2024-03-25 | Morgan Amanda Michelle | Sell | 0 | Common Stock |
2024-03-25 | Morgan Amanda Michelle | Sell | 10 310 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
16.10 |
Last 100 transactions |
Buy: 597 665 | Sell: 442 511 |
Volumen Correlación
Lantheus Holdings Inc Correlación
10 Correlaciones Más Positivas | |
---|---|
PDFS | 0.964 |
LMNR | 0.964 |
RAM | 0.957 |
AMPH | 0.957 |
SGEN | 0.956 |
OMAB | 0.948 |
GEOS | 0.947 |
ALTR | 0.943 |
ANSS | 0.942 |
NSIT | 0.941 |
10 Correlaciones Más Negativas | |
---|---|
WTBA | -0.961 |
FGBI | -0.957 |
GNTY | -0.957 |
ALXO | -0.954 |
ALLK | -0.949 |
ACRX | -0.947 |
TNGX | -0.943 |
AROW | -0.941 |
MICS | -0.941 |
RDVT | -0.94 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Lantheus Holdings Inc Correlación - Moneda/Commodity
Lantheus Holdings Inc Finanzas
Annual | 2023 |
Ingresos: | $1.30B |
Beneficio Bruto: | $709.54M (54.73 %) |
EPS: | $4.79 |
FY | 2023 |
Ingresos: | $1.30B |
Beneficio Bruto: | $709.54M (54.73 %) |
EPS: | $4.79 |
FY | 2022 |
Ingresos: | $935.06M |
Beneficio Bruto: | $581.70M (62.21 %) |
EPS: | $0.410 |
FY | 2021 |
Ingresos: | $425.21M |
Beneficio Bruto: | $187.70M (44.14 %) |
EPS: | $-1.054 |
Financial Reports:
No articles found.
Lantheus Holdings Inc
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for nuclear medicine; Xenon-133 to assess pulmonary function; Neurolite to identify the area within the brain where blood flow has been blocked or reduced due to stroke; Cardiolite, an injectable Tc-99m-labeled imaging agent; Thallium-201 to detect cardiovascular disease; and Gallium-67 to detect various infections and cancerous tumors. The company also offers AZEDRA, a radiotherapeutic to treat adult and pediatric patients; Automated Bone Scan Index that calculates the disease burden of prostate cancer by quantifying the hotspots on bone scans; and Cobalt (Co 57), a non-pharmaceutical radiochemical; RELISTOR for opioid-induced constipation; and PYLARIFY for visualization of lymph nodes, bone, and soft tissue metastases to determine the presence or absence of recurrent and/or metastatic prostate cancer. It also develops flurpiridaz F 18 to assess blood flow to the heart; 1095, a PSMA-targeted iodine-131 labeled small molecule; LMI 1195 for neuroblastoma tumors in pediatric and adults; PYLARIFY AI, an AI-based medical device software to perform standardized quantitative assessment of PSMA PET/CT images in prostate cancer; and leronlimab, an investigational humanized monoclonal antibody. The company serves radio pharmacies, distributors, integrated delivery networks, hospitals, clinics, and group practices. It has strategic partnerships with NanoMab Technology Limited; Bausch Health Companies, Inc.; GE Healthcare Limited; Curium; Bayer AG; CytoDyn Inc.; ROTOP; FUJIFILM; Regeneron Pharmaceuticals, Inc.; and POINT Biopharma US Inc. The company was founded in 1956 and is headquartered in North Billerica, Massachusetts.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico